XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds

75,411 resources

By Version

R2: 0
R2B: 0
R3: 3,448
R4: 55,341
R4B: 3,134
R5: 13,264
R6: 224

By Authority

none: 25,640
hl7: 42,405
ihe: 1,382
national: 3,470
who: 2,514

By Realm

none: 22,398
au: 648
be: 387
br: 299
ca: 764
ch: 1,527
cl: 469
cr: 45
cz: 384
de: 2,066
dk: 1,474
ee: 276
eu: 1,253
fi: 87
fr: 1,545
il: 308
in: 163
it: 181
jp: 293
kr: 5
nl: 2,153
no: 26
nz: 79
pl: 83
se: 29
sl: 2
stt: 116
tw: 901
uk: 97
us: 19,481
uv: 17,592
vn: 107
other: 7

Start Prev Rows 53200 - 53400 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1567	Adolescent Depression Medications	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1568	Follow Up for Adult Depression	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1569	Follow Up for Adolescent Depression	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1570	Referral for Adolescent Depression	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1571	Referral for Adult Depression	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1572	High Intensity Statin Therapy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1573	LDL Cholesterol	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1574	Low Intensity Statin Therapy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1575	Moderate Intensity Statin Therapy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1576	Outpatient Encounters for Preventive Care	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1578	Follow Up Within 4 Weeks	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1580	Referral to Primary Care or Alternate Provider	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1581	Lifestyle Recommendation	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1582	Patient Declined	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1583	Referral or Counseling for Alcohol Consumption	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1584	Hospice Care Ambulatory	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.3000	Metformin	active	2019-12	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.319	Prostate Cancer	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.320	Bone Scan	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.326	Primary Open Angle Glaucoma	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.327	Diabetic Retinopathy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.353	End Stage Renal Disease	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.362	Asthma	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.366	Arrhythmia	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.367	Atrioventricular Block	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.368	Cardiac Pacer in Situ	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.369	Coronary Artery Disease No MI	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.370	Hypotension	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.371	Cardiac Surgery	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.376	Heart Failure	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.378	Pregnancy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.398	Prostate Cancer Treatment	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.399	Salvage Therapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.401	Prostate Specific Antigen Test	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.403	Initial Myocardial Infarction	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.412	Bradycardia	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.451	Pain Warranting Further Investigation for Prostate Cancer	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.471	Bilateral Oophorectomy	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.485	Chemotherapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.509	Tobacco Use Cessation Counseling	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1498	Medications for Above Normal BMI	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1499	Medications for Below Normal BMI	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1519	Follow Up for Above Normal BMI	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1523	Follow Up for Above Normal BMI	active	2017-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1524	Follow Up for BMI Outside Normal Parameters	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1525	Follow Up for Above Normal BMI	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1526	Follow Up for Above Normal BMI	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1527	Referrals Where Weight Assessment May Occur	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1528	Follow Up for Below Normal BMI	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1549	Follow Up for Below Normal BMI	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1550	Follow Up for Below Normal BMI	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1551	Follow Up for Below Normal BMI	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1578	Palliative Care	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1579	Palliative or Hospice Care	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1608	Encounter to Document Medications	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1609	Encounter to Document Medications	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1610	Referrals Where Weight Assessment May Occur	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1751	Encounter to Evaluate BMI	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1834	Encounter to Document Medications	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.1917	Encounter to Document Medications	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.695	Encounter to Evaluate BMI	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.885	Encounter to Evaluate BMI	active	2018-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1.886	Encounter to Evaluate BMI	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1475	Referral to Primary Care or Alternate Provider	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1476	Pharmacologic Therapy for Hypertension	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1482	Laboratory Tests for Hypertension	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1497	Encounter to Screen for Blood Pressure	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1508	Lifestyle Recommendation	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1509	Weight Reduction Recommended	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1510	Weight Reduction Recommended	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1511	Dietary Recommendations	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1512	Dietary Recommendations	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1514	Dietary Recommendations	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1515	Dietary Recommendations	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1516	Exercise Class	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1518	Recommendation to Increase Physical Activity	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1537	Follow Up Within 4 Weeks	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1538	Encounter to Screen for Depression	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1914	Encounter to Screen for Depression	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1915	Encounter to Screen for Depression	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1916	Encounter to Screen for Depression	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1918	Encounter to Screen for Blood Pressure	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.192	Encounter to Screen for Blood Pressure	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.1920	Encounter to Screen for Blood Pressure	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2387	Overweight or Obese	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2388	Underweight	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2395	Finding of Hypertension	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2462	Laboratory Tests for Hypertension	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.2466	Dental Tooth Extraction	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.259	Diagnosis of Hypertension	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.261	Diagnosis of Hypertension	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.263	Diagnosis of Hypertension	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.467	Follow Up for Adolescent Depression	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.468	Follow Up for Adult Depression	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.469	Adolescent Depression Medications	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.470	Adult Depression Medications	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.537	Referral for Adolescent Depression	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.538	Referral for Adult Depression	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.791	Patient Declined	active	2025-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.805	Weight Reduction Recommended	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.810	Recommendation to Increase Physical Activity	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.600.823	Referral or Counseling for Alcohol Consumption	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.6366.117	Absence of Cervix	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.1743	General or Neuraxial Anesthesia	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.1940	Immunocompromised Conditions	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.2262	CABG Surgeries	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.2328	Immunocompromised Conditions I10	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.2343	Immunocompromised Conditions	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.3011	Acute Myocardial Infarction	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.3024	Acute Myocardial Infarction	active	2016-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.307	Encounter Inpatient	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.335	Bone Marrow Transplant	active	2021-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.336	Bone Marrow Transplant	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.404	Bone Marrow Transplant	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.623	Acute Myocardial Infarction	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.694	CABG Surgeries	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.737	PCI	active	2018-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.666.5.747	Endotracheal Intubation	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.128	Bipolar Disorder	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.246	Personality Disorder Emotionally Labile	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.247	Personality Disorder Emotionally Labile	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.248	Personality Disorder Emotionally Labile	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.249	Personality Disorder Emotionally Labile	active	2023-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.254	Dysthymia	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.256	Dysthymia	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.257	Dysthymia	active	2023-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.262	Deceased	active	2014-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.263	PHQ 9 and PHQ 9M Tools	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.269	Hepatitis B	active	2017-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.271	Hepatitis B	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.272	Hepatitis B	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.43	Bipolar Disorder	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.44	Bipolar Disorder	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.1.45	Bipolar Disorder	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.11.721	Deceased	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.67.1.101.11.723	PHQ-9 Tool	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.6929.2.1000	Estimated Glomerular Filtration Rate	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.6929.2.1002	Urine Albumin Creatinine Ratio	active	2025-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.6929.3.1000	Estimated Glomerular Filtration Rate	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.6929.3.1007	Urine Albumin Creatinine Ratio	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1000	Strabismic Amblyopia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1001	Strabismic Amblyopia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1002	Refractive Amblyopia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1003	Refractive Amblyopia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1004	Routine Ophthalmological Examination	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1005	Pediatric Best Corrected Visual Acuity Exam	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1006	LogMAR Visual Acuity Exam	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1007	Aphakia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1008	Aphakia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1009	Infantile and Juvenile Cataract	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1010	Infantile and Juvenile Cataract	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1011	Congenital Corneal or Anterior Segment Conditions	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1012	Congenital Corneal or Anterior Segment Conditions	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1013	Eyelid or Orbital Conditions	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1014	Eyelid or Orbital Conditions	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1015	Coloboma of Optic Disc	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1016	Coloboma of Optic Disc	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1017	Hemorrhage of Optic Nerve Sheath	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1018	Hemorrhage of Optic Nerve Sheath	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1019	Optic Nerve Hypoplasia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1020	Optic Nerve Hypoplasia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1021	Disorder of Visual Cortex Due to Underlying Condition	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1022	Disorder of Visual Cortex Due to Underlying Condition	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1023	Cortical Blindness	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1024	Cortical Blindness	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1025	Congenital Condition of Retina	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.2.1026	Congenital Condition of Retina	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1000	Strabismic Amblyopia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1001	Refractive Amblyopia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1002	Routine Ophthalmological Examination	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1003	Pediatric Best Corrected Visual Acuity Exam	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1004	LogMAR Visual Acuity Exam	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1005	Aphakia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1006	Infantile and Juvenile Cataract	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1007	Congenital Corneal or Anterior Segment Conditions	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1008	Eyelid or Orbital Conditions	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1009	Coloboma of Optic Disc	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1010	Hemorrhage of Optic Nerve Sheath	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1011	Optic Nerve Hypoplasia	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1012	Disorder of Visual Cortex Due to Underlying Condition	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1013	Cortical Blindness	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.8420.3.1014	Congenital Condition of Retina	active	2019-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.88.12.3221.6.2	Allergy and Intolerance Type	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.88.12.3221.7.2	Problem Type (SNOMEDCT)	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.88.12.3221.8.7	SPL Drug Route of Administration Terminology	active	2024-07	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.88.12.80.62	Vital Sign Result Type	active	2024-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3180	NHSNInsertionSiteCode	active	2020-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3181	NHSNRoleOfPerformerCode	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3182	NHSNReasonForInsertionCode	active	2020-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3183	NHSNSkinPreparationCode	active	2020-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3184	NHSNSterileBarrierCode	active	2020-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3185	NHSNCatheterTypeCode	active	2020-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3194	NHSNSignificantPathogenCode	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3195	NHSNCriterionOfDiagnosisCode	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3196	NHSNInfectionConditionCode	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3234	NHSNPopulationCategoryCode	active	2020-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3247	NHSNTimingCode	active	2020-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3248	NHSNEligibilityCode	active	2020-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3249	NHSNSpecimenTypeCode	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.114222.4.11.3283	NHSNOrganismASTCode	active	2020-06	us	hl7